Bing Zou
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer-related Molecular Pathways
Papers in
-
- Cell death mechanisms and regulation 9
- Oncology 40
- Lung Cancer Research Studies 19
- Cancer Immunotherapy and Biomarkers 11
- Co-authors
- Qing Gu (18 shared papers)Benjamin C.Y. Wong (14 shared papers)Hsiang Fu Kung (10 shared papers)Harry Hua‐Xiang Xia (10 shared papers)Jide Wang (10 shared papers)Shui Ping Tu (5 shared papers)Marie C.M. Lin (9 shared papers)Hua He (7 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (7 papers)Cancer Medicine (5 papers)Gastroenterology (4 papers)Journal of Clinical Oncology (4 papers)Cancer (4 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Bing Zou
112 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 137
- Cancer Research 359
- Oncology 563
- Molecular Biology 1.2k
- Polymers and Plastics 225
- Toxicology 54
Countries citing papers authored by Bing Zou
This map shows the geographic impact of Bing Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bing Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bing Zou more than expected).
Fields of papers citing papers by Bing Zou
This network shows the impact of papers produced by Bing Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bing Zou. The network helps show where Bing Zou may publish in the future.
Co-authors
The 25 scholars most cited alongside Bing Zou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 117 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 162 | |
| 2 | Suppression of survivin expression inhibits in vivo tumorigenicity and angiogenesis in gastric cancer. | 2003 | 145 |
| 3 | 2004 | 98 | |
| 4 | 2006 | 88 | |
| 5 | 2017 | 77 | |
| 6 | 2005 | 72 | |
| 7 | 2016 | 72 | |
| 8 | 2009 | 71 | |
| 9 | 2017 | 66 | |
| 10 | 2017 | 63 | |
| 11 | 2009 | 62 | |
| 12 | 2015 | 61 | |
| 13 | 2017 | 61 | |
| 14 | 2005 | 52 | |
| 15 | 2015 | 49 | |
| 16 | Effect of dexmedetomidine on myocardial ischemia-reperfusion injury. | 2015 | 41 |
| 17 | 2006 | 40 | |
| 18 | 2010 | 40 | |
| 19 | 2009 | 39 | |
| 20 | 2019 | 35 |
About Bing Zou
Bing Zou is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Surgery and Cancer Research, having authored 117 papers that have together received 2.5k indexed citations. Recurring topics across this work include Lung Cancer Research Studies (19 papers), Lung Cancer Diagnosis and Treatment (19 papers), Lung Cancer Treatments and Mutations (14 papers), Esophageal Cancer Research and Treatment (12 papers), Radiomics and Machine Learning in Medical Imaging (12 papers), Cancer Immunotherapy and Biomarkers (11 papers), Cell death mechanisms and regulation (9 papers) and Neuroendocrine Tumor Research Advances (8 papers). The work is most often cited by research in Cancer Research (359 citations), Oncology (563 citations), Molecular Biology (1.2k citations), Polymers and Plastics (225 citations) and Toxicology (54 citations). Bing Zou has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Qing Gu, Benjamin C.Y. Wong, Hsiang Fu Kung, Harry Hua‐Xiang Xia, Jide Wang, Shui Ping Tu, Marie C.M. Lin, Hua He, Man‐Fung Yuen and Hui Y. Lan. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer Medicine, Gastroenterology, Journal of Clinical Oncology and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.